IDEXX Laboratories (WKN: 888210) IDXX

Seite 1 von 1
neuester Beitrag: 01.08.20 17:40
eröffnet am: 08.02.18 15:51 von: Tamakoschy Anzahl Beiträge: 8
neuester Beitrag: 01.08.20 17:40 von: Tamakoschy Leser gesamt: 3281
davon Heute: 6
bewertet mit 0 Sternen

08.02.18 15:51

2268 Postings, 3887 Tage TamakoschyIDEXX Laboratories (WKN: 888210) IDXX

http://www.idexx.de/corporate/home.html

https://www.idexx.com/en/about-idexx/investors/


Kurzporträt

Manufactures animal health products

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets.

It operates through the following business segments: Companion Animal Group; Water; Livestock, Poultry, and Dairy; and Other.

The Companion Animal Group segment refers to diagnostic and information technology-based products and services for the veterinary market.

The Water segment includes water quality products for testing of certain microbiological water contaminants.

The Livestock, Poultry, and Dairy segment involves diagnostic, health-monitoring, and food safety testing products for livestock and poultry health, and dairy products.

The Other segment comprises products for the human point-of-care medical diagnostics market with the company's pharmaceutical product line and out-licensing arrangements.

IDEXX Laboratories was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

http://de.4-traders.com/IDEXX-LABORATORIES-9641/...pide&mots=idxx  

11.11.18 20:03

2268 Postings, 3887 Tage TamakoschyEtwas günstiger

01.02.19 14:41

2268 Postings, 3887 Tage TamakoschyQ4 Zahlen schlage Erwartungen

https://www.marketscreener.com/...dexx-4Q-Earnings-Snapshot-27948600/

https://www.marketscreener.com/...nd-Full-Year-2018-Results-27948509/

02/01/2019 | 06:53am EST
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported fourth-quarter earnings of $85.6 million.
The Westbrook, Maine-based company said it had net income of 98 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 90 cents per share.
The Animal diagnostic and health care company posted revenue of $549.4 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $545.6 million.
For the year, the company reported profit of $377 million, or $4.26 per share. Revenue was reported as $2.21 billion.
Idexx expects full-year earnings to be $4.66 to $4.78 per share, with revenue in the range of $2.38 billion to $2.42 billion.

 

01.05.19 16:40

2268 Postings, 3887 Tage Tamakoschyq1 wieder über Erwartungen

https://www.marketscreener.com/...dexx-1Q-Earnings-Snapshot-28514373/

05/01/2019 | 06:45am EDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Wednesday reported first-quarter earnings of $102.7 million.
On a per-share basis, the Westbrook, Maine-based company said it had net income of $1.17.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.04 per share.
The Animal diagnostic and health care company posted revenue of $576.1 million in the period.
Idexx expects full-year earnings to be $4.76 to $4.88 per share, with revenue in the range of $2.38 billion to $2.42 billion.
Idexx shares have increased 25% since the beginning of the year. The stock has risen 19% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX
Automated Insights, source Associated Press News  

31.10.19 18:07

2268 Postings, 3887 Tage TamakoschyQ3 Über Erwartungen

https://www.marketscreener.com/...ondition-and-Results-of-O-29492368/

https://www.marketscreener.com/...dexx-3Q-Earnings-Snapshot-29489583/

Idexx: 3Q Earnings Snapshot

10/31/2019 | 06:46am EDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Thursday reported third-quarter net income of $108.8 million.
The Westbrook, Maine-based company said it had net income of $1.24 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.13 per share.
The Animal diagnostic and health care company posted revenue of $605.3 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $597.4 million.
Idexx expects full-year earnings to be $4.72 to $4.78 per share, with revenue expected to be $2.4 billion.
Idexx shares have risen 47% since the beginning of the year. The stock has climbed 30% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX
Automated Insights, source Associated Press News

 

02.02.20 16:01

2268 Postings, 3887 Tage TamakoschyQ4 über Erwartungen - Kurs hat trotzdem Schnupfen

https://www.marketscreener.com/...dexx-4Q-Earnings-Snapshot-29920185/

Idexx: 4Q Earnings Snapshot

01/31/2020 | 06:59am EST
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported fourth-quarter earnings of $90.5 million.
On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.04.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 91 cents per share.
The Animal diagnostic and health care company posted revenue of $605.4 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $599.9 million.
For the year, the company reported profit of $427.7 million, or $4.89 per share. Revenue was reported as $2.41 billion.
Idexx expects full-year earnings to be $5.42 to $5.58 per share, with revenue in the range of $2.62 billion to $2.66 billion.
Idexx shares have risen roughly 9% since the beginning of the year. The stock has increased 37% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX
Automated Insights, source Associated Press News

https://www.marketscreener.com/...nd-Full-Year-2019-Results-29920019/

Achieves revenue growth in Q4 of 10% on a reported and organic basis, driven by CAG Diagnostics recurring revenue reported and organic growth of 11%
Reports 19% year-over-year increase in Catalyst placements at new and competitive accounts in Q4, supporting full year growth of 16% in IDEXX's premium instrument installed base
Delivers full year EPS of $4.89, representing 15% growth on a reported basis and 21% on a comparable constant currency basis
Increases 2020 revenue guidance to $2,620 million - $2,655 million, reflecting consistent expectations for reported and organic revenue growth of 9% - 10.5%
Raises 2020 EPS outlook range by $0.12 to $5.42 - $5.58, reflecting expectations for continued strong operating trends, higher estimates for share-based compensation tax benefits and favorable adjustments to projected foreign exchange rates impacts
 

06.05.20 21:17

2268 Postings, 3887 Tage TamakoschyQ1 2020

https://www.marketscreener.com/...dexx-1Q-Earnings-Snapshot-30502962/

Idexx: 1Q Earnings Snapshot
share with twitter share with LinkedIn share with facebook share via e-mail
0
04/30/2020 | 11:45am BST
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Thursday reported first-quarter profit of $111.8 million.

On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.29.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.23 per share.

The Animal diagnostic and health care company posted revenue of $626.3 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $631.8 million.

Idexx shares have risen slightly more than 4% since the beginning of the year. The stock has climbed 18% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX

Automated Insights, source Associated Press News  

01.08.20 17:40

2268 Postings, 3887 Tage TamakoschyQ2 Gute Zahlen

https://www.marketscreener.com/...dexx-2Q-Earnings-Snapshot-31029808/

dexx: 2Q Earnings Snapshot

07/31/2020 | 11:42am BST
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported second-quarter profit of $148.9 million.

On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.72.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.20 per share.

The Animal diagnostic and health care company posted revenue of $637.6 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $580 million.

Idexx shares have risen 43% since the beginning of the year. The stock has risen 31% in the last 12 months.

 

   Antwort einfügen - nach oben

  3 Nutzer wurden vom Verfasser von der Diskussion ausgeschlossen: Ciriaco, phre22, stahlfaust